Cytek Biosciences (CTKB)
(Delayed Data from NSDQ)
$3.64 USD
+0.04 (1.11%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $3.64 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth C Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Cytek Biosciences, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
CTKB 3.64 +0.04(1.11%)
Will CTKB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CTKB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CTKB
Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Lags Revenue Estimates
Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates
CTKB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cytek Biosciences, Inc. (CTKB) Tops Q4 Earnings Estimates
Dynavax Technologies (DVAX) Surpasses Q4 Earnings and Revenue Estimates
Cytek Biosciences, Inc. (CTKB) Q3 Earnings and Revenues Beat Estimates
Other News for CTKB
Cytek Biosciences Elects New Directors at Annual Meeting
Analysts Conflicted on These Healthcare Names: Cytek Biosciences (CTKB), Dexcom (DXCM) and Solid Biosciences (SLDB)
CFO Makes Bold Move with Major Stock Purchase in Cytek Biosciences!
Insider Buying: William Mccombe Acquires 35,000 Shares of Cytek Biosciences Inc (CTKB)